Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Genentech claims checkpoint kinase Chk1 inhibitors for cancer therapy

Jan. 19, 2010

FDA extends review period for OSI's sNDA for Tarceva in non-small cell lung cancer

Jan. 19, 2010

BioCryst achieves enrollment target in pivotal forodesine study

Jan. 19, 2010

TGen Drug Development and Critical Outcome Technologies to collaborate on COTI-2

Jan. 19, 2010

Novel janus kinase inhibitors disclosed by AstraZeneca

Jan. 18, 2010

Genentech describes novel checkpoint kinase inhibitors as oncolytics

Jan. 18, 2010

Ixabepilone not active in childhood solid tumors

Jan. 18, 2010

NVP-BEZ235 may enhance activity of cytotoxic agents in sarcoma

Jan. 18, 2010

Laromustine/cytarabine activity in relapsed acute myeloid leukemia to be studied further

Jan. 18, 2010

Infinity outlines key objectives for 2010

Jan. 18, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026